Alzheimer’s Big Break: Donanemab Slows Progression by 35%

Alzheimer’s disease made lives difficult. It also remains a challenge for scientists and healthcare providers. For many years, the search for effective treatments seemed fruitless. Then, two years ago, the medical community broke into massive optimisim. Breakthrough research introduced new drugs that could change the course of the disease. One of these drugs, donanemab, has […]